Inventor · disambiguated record
Peter J. Machin
Also filed as: MACHIN PETER · MACHIN PETER J · MACHIN PETER JAMES
23 granted patents·4 pending applications·333 citations·filing 1981–2025
95Inventor score
Files withHOFFMANN LA ROCHE13ENYO PHARMA6ARTAX BIOPHARMA INC5GENKYOTEX SUISSE SA2CALLIDITAS THERAPEUTICS SUISSE SA1
Top patents by PatentIndex Score
27 records- 0197US5157041AAmino acid derivativesHOFFMANN LA ROCHE·Filed 1989·Granted Oct 20, 1992·117 cites·19 claims
- 0292US4996358AHydroxylamine bearing amino acid derivatives as collagenase inhibitorsHOFFMANN LA ROCHE·Filed 1989·Granted Feb 26, 1991·84 cites·36 claims
- 0386US11807633B2Chromene derivatives as inhibitors of TCR-Nck interactionARTAX BIOPHARMA INC·Filed 2021·Granted Nov 7, 2023·1 cites·20 claims
- 0484US10696663B2Chromene derivatives as inhibitors of TCR-NCK interactionARTAX BIOPHARMA INC·Filed 2019·Granted Jun 30, 2020·2 cites·21 claims
- 0583US12319675B2Chromene derivatives as inhibitors of TCR-Nck interactionARTAX BIOPHARMA INC·Filed 2023·Granted Jun 3, 2025·0 cites·2 claims
- 0682US11008310B2Chromene derivatives as inhibitors of TCR-Nck interactionARTAX BIOPHARMA INC·Filed 2020·Granted May 18, 2021·1 cites·22 claims
- 0779US11492347B2Fused thiophene derivatives and their usesENYO PHARMA·Filed 2019·Granted Nov 8, 2022·1 cites·12 claims
- 0879US4387100ASubstituted phenoxy-aminopropanol derivativesHOFFMANN LA ROCHE·Filed 1981·Granted Jun 7, 1983·9 cites·10 claims
- 0978US2025346586A1Chromene derivatives as inhibitors of tcr-nck interactionARTAX BIOPHARMA INC·Filed 2025·Application pending·0 cites
- 1076US10130619B2Amido thiadiazole derivatives as NADPH oxidase inhibitorsGENKYOTEX SUISSE SA·Filed 2015·Granted Nov 20, 2018·3 cites·12 claims
- 1172US4885283APhosphinic acid derivativesHOFFMANN LA ROCHE·Filed 1987·Granted Dec 5, 1989·40 cites·38 claims
- 1272US4774253AOxazole and isoxazole derivatives having anti-arthritic activityHOFFMANN LA ROCHE·Filed 1986·Granted Sep 27, 1988·11 cites·18 claims
- 1367US5652369AAmino acid derivativesHOFFMANN LA ROCHE·Filed 1995·Granted Jul 29, 1997·17 cites·14 claims
- 1467US5006651APhosphinic acid derivativesHOFFMANN LA ROCHE·Filed 1989·Granted Apr 9, 1991·19 cites·13 claims
- 1562US4577030AAzolyl-substituted phenoxy-aminopropanol derivativesHOFFMANN LA ROCHE·Filed 1983·Granted Mar 18, 1986·3 cites·4 claims
- 1661US5620987AAmino acid derivativesHOFFMANN LA ROCHE·Filed 1995·Granted Apr 15, 1997·12 cites·11 claims
- 1761US4649160ASubstituted phenoxy-aminopropanolsHOFFMANN LA ROCHE·Filed 1985·Granted Mar 10, 1987·9 cites·15 claims
- 1860US11603368B2Fused thiophene derivatives and their usesENYO PHARMA·Filed 2019·Granted Mar 14, 2023·0 cites·2 claims
- 1959US11840527B2Non-fused thiophene derivatives and their usesENYO PHARMA·Filed 2019·Granted Dec 12, 2023·0 cites·8 claims
- 2058US11767316B2Non-fused thiophene derivatives and their usesENYO PHARMA·Filed 2019·Granted Sep 26, 2023·0 cites·9 claims
- 2155US4663462ASubstituted phenoxy-aminopropanol derivativesHOFFMANN LA ROCHE·Filed 1985·Granted May 5, 1987·3 cites·23 claims
- 2250US2022251028A1Tertiary amine derivatives and their uses for treating a viral infectionENYO PHARMA·Filed 2020·Application pending·0 cites
- 2348US2023150978A1Quinazolinone derivatives and uses thereof for treating a cancerENYO PHARMA·Filed 2021·Application pending·0 cites
- 2446US2019046515A1Amido thiadiazole derivatives as nadph oxidase inhibitorsGENKYOTEX SUISSE SA·Filed 2018·Application pending·0 cites
- 2539US12202816B2Compounds as NADPH oxidase inhibitorsCALLIDITAS THERAPEUTICS SUISSE SA·Filed 2019·Granted Jan 21, 2025·0 cites·21 claims
- 2636US5446161AAmino acid derivativesHOFFMANN LA ROCHE·Filed 1992·Granted Aug 29, 1995·1 cites·14 claims
- 2732US5554756AAmino acid derivativesHOFFMANN LA ROCHE·Filed 1995·Granted Sep 10, 1996·0 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when Peter J. Machin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →